Nicole Lambert

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Salt Lake City, UT
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Carolyn Tang, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Nicole Lambert

Form 4 holding Chief Operating Officer

MYRIAD GENETICS INC

Security class
Common Stock
Shares / value
223,993
Estimated value
$4,287,226
Report date
31 Oct 2023
Price
$19.14
Ownership
Direct

Insider Reports Filed by Nicole Lambert

4 MYGN

MYRIAD GENETICS INC

Report period
08 Dec 2021
Transactions
1
Transaction value
$0
Accepted by SEC
10 Dec 2021, 15:39
Role
Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Next action
Open filing details
4 MYGN

MYRIAD GENETICS INC

Report period
09 Oct 2021
Transactions
2
Transaction value
-$385,475
Accepted by SEC
12 Oct 2021, 16:46
Role
Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Next action
Open filing details
4 MYGN

MYRIAD GENETICS INC

Report period
01 Oct 2021
Transactions
1
Transaction value
-$44,835
Accepted by SEC
04 Oct 2021, 16:16
Role
Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Next action
Open filing details
4 MYGN

MYRIAD GENETICS INC

Report period
25 Sep 2021
Transactions
3
Transaction value
-$492,536
Accepted by SEC
27 Sep 2021, 21:13
Role
Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Next action
Open filing details
4 MYGN

MYRIAD GENETICS INC

Report period
21 Sep 2021
Transactions
1
Transaction value
$0
Accepted by SEC
23 Sep 2021, 17:24
Role
Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Next action
Open filing details
4 MYGN

MYRIAD GENETICS INC

Report period
27 Aug 2021
Transactions
1
Transaction value
-$32,602
Accepted by SEC
30 Aug 2021, 16:11
Role
Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Next action
Open filing details
4 MYGN

MYRIAD GENETICS INC

Report period
25 Aug 2021
Transactions
1
Transaction value
-$39,092
Accepted by SEC
26 Aug 2021, 21:55
Role
Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .